Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Humanization of an anti-p185HER2 antibody for human cancer therapy.
19921.5k citationsPaul Carter, Leonard G. Presta et al.Proceedings of the National Academy of Sciencesprofile →
Hydrogen bonding and biological specificity analysed by protein engineering
1985887 citationsPaul Carter, Greg Winter et al.profile →
Spectrophotometric determination of serum iron at the submicrogram level with a new reagent (ferrozine)
This map shows the geographic impact of Paul Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Carter more than expected).
This network shows the impact of papers produced by Paul Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Carter. The network helps show where Paul Carter may publish in the future.
Co-authorship network of co-authors of Paul Carter
This figure shows the co-authorship network connecting the top 25 collaborators of Paul Carter.
A scholar is included among the top collaborators of Paul Carter based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Paul Carter. Paul Carter is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Carter, Paul, et al.. (2016). Languages in the world : how history, culture, and politics shape language. Wiley-Blackwell eBooks.9 indexed citations
5.
Carter, Paul. (2015). Places made after their stories: design and the art of choreotopography. RMIT Research Repository (RMIT University Library).1 indexed citations
Carter, Paul, et al.. (2011). Early Results of the English Communication Course. 61–65.
8.
Gerber, Hans‐Peter, Ivan J. Stone, Mechthild Jonas, et al.. (2007). Humanized anti-CD19 auristatin antibody-drug conjugates display potent antitumor activity in preclinical models of B-cell malignancies. Molecular Cancer Therapeutics. 6.2 indexed citations
9.
Carter, Sarah, et al.. (2006). Skier Triggered Surface Hoar: A Discussion of Avalanche Involvements During the 2006 Valdez Chugach Helicopter Ski Season. 860–867.1 indexed citations
10.
Carter, Paul, Shakti Chauhan, & John Walker. (2006). Sorting Logs and Lumber for Stiffness Using Director HM200. Wood and Fiber Science. 38(1). 49–54.36 indexed citations
11.
Carter, Paul. (2003). Speaking volumes : Gaston Bachelard and the showing of the word. Architectural Design. 72(2). 11–13.1 indexed citations
12.
Carter, Paul. (2001). Bispecific human IgG by design. Journal of Immunological Methods. 248(1-2). 7–15.127 indexed citations
13.
Carter, Paul, et al.. (2000). Non‐epithelial ovarian cancers. The Obstetrician & Gynaecologist. 2(2). 37–39.2 indexed citations
14.
Grimm, Jacob, et al.. (1999). Fairy tales from Grimm. University of Florida Digital Collections (University of Florida).
Rodrigues, Maria Luı́sa, Leonard G. Presta, Claire E. Kotts, et al.. (1995). Development of a humanized disulfide-stabilized anti-p185HER2 Fv-beta-lactamase fusion protein for activation of a cephalosporin doxorubicin prodrug.. PubMed. 55(1). 63–70.66 indexed citations
Carter, Paul, Leonard G. Presta, C Gorman, et al.. (1992). Humanization of an anti-p185HER2 antibody for human cancer therapy.. Proceedings of the National Academy of Sciences. 89(10). 4285–4289.1483 indexed citations breakdown →
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.